[27P2-pm2] Clinical Pharmacy 3

[27P2-pm2-129] Proton pump inhibitor or vonoprazan use are associated with occurrence of febrile neutropenia in patients with small-cell lung cancer receiving carboplatin plus etoposide

○Masaya Takahashi^1,2, Katsuyuki Takahashi², Hiroyasu Kaneda³, Tomoya Kawaguchi^3,4, Toru Otori², Yasutaka Nakamura¹ (1. Department of Pharmacy, Osaka Metropolitan University, 2. Division of Clinical Pharmacy, Faculty of Pharmacy, Kinki University, 3. Department of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, 4. Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University)